Skip to main content
TipRanks
Go Ultimate75% OFF

Emmaus Life Sciences (EMMA) Ratios

89 Followers

Emmaus Life Sciences Ratios

EMMA's free cash flow for Q2 2026 was $1.69M. For the 2026 fiscal year, EMMA's free cash flow was decreased by $-2.00K and operating cash flow was $1.69M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Jun 24Dec 22Mar 22
Liquidity Ratios
Current Ratio0.110.110.190.120.25
Quick Ratio0.090.080.160.070.13
Cash Ratio0.030.020.040.040.06
Solvency Ratio-0.09-0.08-0.04-0.13-0.20
Operating Cash Flow Ratio-0.00-0.04-0.02-0.09-0.03
Short-Term Operating Cash Flow Coverage-0.00-0.08-0.05-0.21-0.06
Net Current Asset Value$ -77.30M$ -73.31M$ -71.43M$ -76.03M$ -69.09M
Leverage Ratios
Debt-to-Assets Ratio1.521.400.930.640.53
Debt-to-Equity Ratio-0.51-0.58-0.68-0.90-1.39
Debt-to-Capital Ratio-1.05-1.40-2.16-9.423.53
Long-Term Debt-to-Capital Ratio-0.04-0.04-0.05-0.12-0.28
Financial Leverage Ratio-0.34-0.42-0.74-1.41-2.64
Debt Service Coverage Ratio-0.01-0.030.10-0.19-0.51
Interest Coverage Ratio0.03-0.340.48-1.31-1.98
Debt to Market Cap37.0055.305.632.140.32
Interest Debt Per Share0.620.610.750.720.67
Net Debt to EBITDA-98.17-34.708.31-5.24-2.17
Profitability Margins
Gross Profit Margin93.12%92.79%95.47%85.93%83.93%
EBIT Margin-2.80%-5.60%12.13%-30.19%-62.20%
EBITDA Margin-2.49%-5.46%12.24%-29.90%-61.92%
Operating Profit Margin1.85%-11.37%11.96%-35.81%-29.73%
Pretax Profit Margin-60.09%-38.58%-12.81%-57.45%-77.25%
Net Profit Margin-60.16%-38.75%-12.61%-57.78%-77.37%
Continuous Operations Profit Margin-60.16%-38.75%-12.61%-57.78%-77.37%
Net Income Per EBT100.12%100.45%98.44%100.57%100.16%
EBT Per EBIT-3239.39%339.18%-107.12%160.42%259.81%
Return on Assets (ROA)-34.95%-27.34%-10.61%-22.03%-28.11%
Return on Equity (ROE)11.78%11.43%7.82%31.17%74.34%
Return on Capital Employed (ROCE)-0.48%4.74%-13.45%108.00%-31.21%
Return on Invested Capital (ROIC)-1.23%18.84%154.41%-35.71%-14.46%
Return on Tangible Assets-34.95%-27.34%-10.61%-22.03%-28.11%
Earnings Yield-899.94%-1200.56%-70.24%-82.56%-19.39%
Efficiency Ratios
Receivables Turnover4.446.355.3649.0419.82
Payables Turnover0.210.361.048.6012.64
Inventory Turnover0.550.730.781.090.75
Fixed Asset Turnover14.1710.5712.356.405.67
Asset Turnover0.580.710.840.380.36
Working Capital Turnover Ratio-0.21-0.31-0.60-0.48-1.03
Cash Conversion Cycle-973.63-450.04182.08300.51473.57
Days of Sales Outstanding82.1957.4968.127.4418.42
Days of Inventory Outstanding662.28496.90465.36335.52484.02
Days of Payables Outstanding1718.101004.43351.4042.4528.87
Operating Cycle744.47554.39533.49342.97502.44
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.04-0.03-0.10-0.03
Free Cash Flow Per Share-0.00-0.04-0.03-0.10-0.03
Dividend Paid and CapEx Coverage Ratio-11.00-190.50-88.41-195.12-17.18
Capital Expenditure Coverage Ratio-11.00-190.50-88.41-195.12-17.18
Operating Cash Flow Coverage Ratio-0.00-0.07-0.05-0.16-0.04
Operating Cash Flow to Sales Ratio-0.00-0.14-0.05-0.28-0.06
Free Cash Flow Yield-1.44%-427.54%-28.60%-39.62%-1.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.11-0.09-1.42-1.21-5.16
Price-to-Sales (P/S) Ratio0.070.030.180.703.99
Price-to-Book (P/B) Ratio-0.01-0.01-0.11-0.38-3.83
Price-to-Free Cash Flow (P/FCF) Ratio-69.38-0.23-3.50-2.52-61.98
Price-to-Operating Cash Flow Ratio-75.68-0.24-3.54-2.54-65.59
Price-to-Earnings Growth (PEG) Ratio-0.01-0.000.020.040.00
Enterprise Value Multiple-100.85-35.299.78-7.58-8.61
Enterprise Value31.26M32.11M35.42M41.67M109.89M
EV to EBITDA-100.85-35.299.78-7.58-8.61
EV to Sales2.511.931.202.275.33
EV to Free Cash Flow-2605.38-13.97-23.30-8.17-82.81
EV to Operating Cash Flow-2842.23-14.05-23.56-8.21-87.63
Tangible Book Value Per Share-0.99-0.89-0.90-0.69-0.44
Shareholders’ Equity Per Share-0.99-0.89-0.90-0.69-0.44
Tax and Other Ratios
Effective Tax Rate-0.00-0.000.02-0.01-0.00
Revenue Per Share0.190.260.560.370.42
Net Income Per Share-0.12-0.10-0.07-0.21-0.32
Tax Burden1.001.000.981.011.00
Interest Burden21.446.89-1.061.901.24
Research & Development to Revenue0.030.040.040.090.20
SG&A to Revenue0.891.000.500.720.65
Stock-Based Compensation to Revenue0.000.020.040.000.03
Income Quality0.000.350.400.480.08

Currency in USD